Lisata Therapeutics, Inc. (LSTA)

NASDAQ: LSTA · Real-Time Price · USD

3.182

+0.062 (1.99%)

At close: Apr 28, 2026, 4:00 PM EDT

3.200

+0.018 (0.57%)

After-hours: Apr 28, 2026, 4:00 PM EDT

Lisata Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Lisata Therapeutics stock has a target of 15, which predicts an increase of 371.40% from the current stock price of 3.18.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$15	$15	$15	$15
Change	+371.40%	+371.40%	+371.40%	+371.40%

* Price targets were last updated on Aug 21, 2025.

Analyst Ratings

The average analyst rating for Lisata Therapeutics stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kemp Dolliver Brookline Capital	Brookline Capital	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jan 21, 2026
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $15	Strong Buy	Reiterates	$15	+371.40%	Aug 21, 2025
Kemp Dolliver Brookline Capital	Brookline Capital	Strong Buy Maintains $20 → $32	Strong Buy	Maintains	$20 → $32	+905.66%	Jul 15, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $15	Strong Buy	Reiterates	$15	+371.40%	Dec 11, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $15	Strong Buy	Reiterates	$15	+371.40%	Nov 21, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 170.00K

Revenue Next Year

10.20M

EPS This Year

-0.98

from -1.91

EPS Next Year

-0.67

from -0.98

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	1.00M	170.00K	-	10.20M
Revenue Growth	-	-	-	-	-83.00%	-	-
EPS	-7.45	-10.47	-2.58	-2.40	-1.91	-0.98	-0.67
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	10.5M
Avg	n/a	10.2M
Low	n/a	9.8M

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.01	-0.69
Avg	-0.98	-0.67
Low	-0.94	-0.65

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.